Joint AUBAGIO® (teriflunomide) & LEMTRADA® (alemtuzumab) Academy of Knowledge Meeting – 17-18 November 2017, Berlin
 
GLOBAL
Tjerk J. Bultsma
Director Global Marketing – Multiple Sclerosis

Meeting & Events
Alison Grainger
Meeting & Events Specialist